Tuning Reactivity of Platinum(II) Complexes

References
1 E. M. Walker and S. M. Walker, , Annals of Clinical and Laboratory Science, 1999,
29, 263.
2 A. Jamal, F. Bray, M. M. Centre, M. E. Jacques Ferlay, E. Ward and D. Forman, CA
Cancer J. Clin., 2011, 61, 69.
3. B. Kumar, P. R.Yadav, H. C. Goel, M. Moshahid, and A. Rizvi, Digest J.
Nanomaterials and Biostructures, 2009, 4, 1.
4 Pan American Health Organization, Regional Office of the World Health
Organisation (WHO), Cancer (WHO Fact Sheet No. 297), 24/Oct/2006.
5 Y. Ho, S. F. Au-Yeung and K. W. To, Med. Res. Rev., 2003, 23, 633.
6 M. Pan and C. Ho, Chem. Soc. Rev., 2008, 37, 2558
7 (a)R.A. Weinberg, How cancer arises: Sci. Am., 2006, 275, 62; (b) M. A. Jakubec, M.
Galanski and B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1-53.
8 P. C. A. Bruijnincx and P. J. Sadler, Adv Inorg Chem., 2009, 61:1–62.
9 M. A. Jakupec, M. Galanski, V. B. Arion, C. G. Hartinger and B. K. Keppler, Dalton
Trans., 2008, 183–194.
10 M. Glanski, M. A. Jakupec and B. K. Keppler, Curr. Med. Chem., 2005, 12, 225.
11 (a) M. J. Hannon, Pure Appl. Chem., 2007, 79, 2243; (b) L. M. Pasetto, M. A.
D’Andrea, A. A. Brandes, E. Rossi, S. Monfardini, Critic. Rev. Onco. / Hemat., 2006,
59; (c) C. J. Jones and J. Thornback, Medicinal Applications of Coordination
Chemistry, RSC Publishing, Cambridge, UK, 2007, pp. 218-257.
12 D. C. G. J, Baquiran. Lippincott's Cancer Chemotherapy Handbook, Lippincott.
1998.
13 T. Boulikas, A. Pantos, E. Bellis and P. Christofis, Cancer Therapy, 2007, 5, 537.
14 B. E. Lippert, Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug.
Wiley-VCH: Zürich, 1999; p 183-221.
15 U. Belluco, Organometallic and Coordination Chemistry of Platinum, Academic
Press, London, 1974, pp. v, vi, 1, 2, 19, 20.
16 F.A. Cotton, G. Wilkinson and P. L. Gaus, Basic Inorganic Chemistry, 3rd Ed. John
Wiley & Sons, Inc., New York, 1995, pp. 229, 597-599, 605, 606.
20